Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Friday, March 24, 2023
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Bayer’s Nubeqa™ approved for additional prostate cancer indication in China
admin
-
March 21, 2023
Latest Pharma-News
FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products
admin
-
March 21, 2023
Latest Pharma-News
Pfizer’s XTANDI® plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer
admin
-
March 20, 2023
Latest Pharma-News
FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products
admin
-
March 20, 2023
Latest Pharma-News
Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments
admin
-
March 17, 2023
Latest Pharma-News
FDA Authorizes Copenhagen Classic Snuff to be Marketed as a Modified Risk Tobacco Product
admin
-
March 17, 2023
0
Latest Pharma-News
Sanofi to acquire Provention Bio, adding to portfolio TZIELD for type diabetes (T1D)
admin
-
March 14, 2023
0
Latest Pharma-News
LEO Pharma and ICON enter a Strategic Partnership on clinical trial mission
admin
-
March 13, 2023
0
Latest Pharma-News
AstraZeneca launches call for entries to 2023 global R&D Postdoctoral Challenge
admin
-
March 13, 2023
0
Latest Pharma-News
Pfizer’s ZAVZPRET™ Migraine Nasal Spray Receives FDA Approval
admin
-
March 10, 2023
0
Latest Pharma-News
FDA Seeks $7.2 Billion to Protect and Advance Public Health
admin
-
March 10, 2023
0
Latest Pharma-News
AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge
admin
-
March 10, 2023
0
Latest Pharma-News
New organ-on-chip pilot seeks to reduce animal testing in consumer health industry
admin
-
March 9, 2023
0
Latest Pharma-News
FDA Proposes New Requirements for Tobacco Product Manufacturing Practices
admin
-
March 9, 2023
0
Latest Pharma-News
Imfinzi significantly improved event-free survival in AEGEAN Phase III trial for patients with resectable nSCLC
admin
-
March 9, 2023
0
Latest Pharma-News
Bayer’s Nubeqa™ receives EU approval for additional indication in prostate cancer
admin
-
March 6, 2023
0
Latest Pharma-News
AstraZeneca and Daiichi Sankyo’s Enhertu met prespecified criteria for objective response rate and duration of response
admin
-
March 6, 2023
0
1
2
3
...
141
Page 1 of 141
- Advertisment -
Most Read
Bayer’s Nubeqa™ approved for additional prostate cancer indication in China
March 21, 2023
FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products
March 21, 2023
Pfizer’s XTANDI® plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer
March 20, 2023
FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products
March 20, 2023